Literature DB >> 29649990

Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy.

Kim A Brogden1, Deepak Parashar2, Andrea R Hallier3, Terry Braun3, Fang Qian4,5, Naiyer A Rizvi6, Aaron D Bossler7, Mohammed M Milhem8, Timothy A Chan9, Taher Abbasi10, Shireen Vali10.   

Abstract

It has been highlighted that in the original manuscript [1] Table S3 'An example of the predictive computational modeling process. Specific details on an annexure section of the PD-L1 pathway show the step-by-step reactions, mechanisms, and reaction equations that occur. Such reactions also occurred in all of the other pathways' was omitted and did not appear in the Additional files and that the Additional files were miss-numbered thereafter. This Correction shows the correct and incorrect Additional files. The original article has been updated.

Entities:  

Year:  2018        PMID: 29649990      PMCID: PMC5898039          DOI: 10.1186/s12885-018-4200-5

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


Correction

It has been highlighted that in the original manuscript [1] Table S3 ‘An example of the predictive computational modeling process. Specific details on an annexure section of the PD-L1 pathway show the step-by-step reactions, mechanisms, and reaction equations that occur. Such reactions also occurred in all of the other pathways’ was omitted and did not appear in the Additional files. The original article has been updated.
  1 in total

1.  Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy.

Authors:  Kim A Brogden; Deepak Parashar; Andrea R Hallier; Terry Braun; Fang Qian; Naiyer A Rizvi; Aaron D Bossler; Mohammed M Milhem; Timothy A Chan; Taher Abbasi; Shireen Vali
Journal:  BMC Cancer       Date:  2018-02-27       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.